Rice Hall James & Associates, LLC Bio Techne Corp Transaction History

Rice Hall James & Associates, LLC

  • $1.53 Billion
  • Q1 2025

A detailed history of Rice Hall James & Associates, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 10,061 shares of TECH stock, worth $470,653. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,061
Previous 10,020 0.41%
Holding current value
$470,653
Previous $721,000 18.31%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025
BUY
$58.47 - $78.75 $2,397 - $3,228
41 Added 0.41%
10,061 $589,000
Q4 2024

Jan 31, 2025
SELL
$66.37 - $78.17 $265 - $312
-4 Reduced 0.04%
10,020 $721,000
Q3 2024

Oct 28, 2024
SELL
$70.96 - $82.35 $15,185 - $17,622
-214 Reduced 2.09%
10,024 $801,000
Q2 2024

Aug 07, 2024
SELL
$62.12 - $84.15 $3,789 - $5,133
-61 Reduced 0.59%
10,238 $733,000
Q1 2024

Apr 23, 2024
SELL
$65.98 - $77.09 $272,695 - $318,612
-4,133 Reduced 28.64%
10,299 $724,000
Q3 2023

Nov 02, 2023
SELL
$67.52 - $89.42 $540 - $715
-8 Reduced 0.06%
14,432 $982,000
Q2 2023

Jul 24, 2023
SELL
$73.76 - $85.98 $591,112 - $689,043
-8,014 Reduced 35.69%
14,440 $1.18 Million
Q1 2023

May 11, 2023
SELL
$71.62 - $86.62 $17,618 - $21,308
-246 Reduced 1.08%
22,454 $1.67 Million
Q4 2022

Jan 27, 2023
BUY
$80.67 - $352.29 $1.29 Million - $5.62 Million
15,942 Added 235.9%
22,700 $0
Q3 2022

Nov 01, 2022
SELL
$282.54 - $391.85 $22,038 - $30,564
-78 Reduced 1.14%
6,758 $1.92 Million
Q2 2022

Aug 08, 2022
SELL
$322.67 - $449.65 $41,947 - $58,454
-130 Reduced 1.87%
6,836 $2.37 Million
Q1 2022

May 05, 2022
SELL
$353.85 - $487.79 $32,200 - $44,388
-91 Reduced 1.29%
6,966 $3.02 Million
Q3 2021

Nov 09, 2021
SELL
$444.87 - $538.88 $88,974 - $107,776
-200 Reduced 2.76%
7,057 $3.42 Million
Q2 2021

Jul 29, 2021
SELL
$387.35 - $450.26 $443,515 - $515,547
-1,145 Reduced 13.63%
7,257 $3.27 Million
Q1 2021

May 14, 2021
SELL
$314.62 - $411.0 $303,922 - $397,026
-966 Reduced 10.31%
8,402 $3.21 Million
Q4 2020

Feb 16, 2021
SELL
$246.9 - $321.87 $384,670 - $501,473
-1,558 Reduced 14.26%
9,368 $2.98 Million
Q3 2020

Nov 16, 2020
SELL
$232.22 - $282.96 $157,677 - $192,129
-679 Reduced 5.85%
10,926 $2.71 Million
Q2 2020

Aug 14, 2020
SELL
$185.43 - $279.56 $40,980 - $61,782
-221 Reduced 1.87%
11,605 $3.07 Million
Q1 2020

May 15, 2020
SELL
$161.17 - $221.51 $35,940 - $49,396
-223 Reduced 1.85%
11,826 $2.24 Million
Q4 2019

Jan 29, 2020
SELL
$189.68 - $222.09 $16,122 - $18,877
-85 Reduced 0.7%
12,049 $2.65 Million
Q3 2019

Oct 30, 2019
SELL
$183.56 - $216.72 $203,751 - $240,559
-1,110 Reduced 8.38%
12,134 $2.37 Million
Q2 2019

Aug 01, 2019
SELL
$188.72 - $215.43 $28,685 - $32,745
-152 Reduced 1.13%
13,244 $2.76 Million
Q1 2019

May 01, 2019
SELL
$136.09 - $200.44 $171,473 - $252,554
-1,260 Reduced 8.6%
13,396 $2.66 Million
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $23,762 - $36,480
-179 Reduced 1.21%
14,656 $2.12 Million
Q3 2018

Oct 25, 2018
SELL
$147.44 - $204.11 $387,177 - $535,992
-2,626 Reduced 15.04%
14,835 $3.03 Million
Q2 2018

Aug 02, 2018
SELL
$144.9 - $165.58 $249,952 - $285,625
-1,725 Reduced 8.99%
17,461 $2.58 Million
Q1 2018

Apr 25, 2018
SELL
$131.46 - $151.04 $11,174 - $12,838
-85 Reduced 0.44%
19,186 $2.9 Million
Q4 2017

Jan 23, 2018
SELL
$121.17 - $134.75 $275,419 - $306,286
-2,273 Reduced 10.55%
19,271 $2.5 Million
Q3 2017

Oct 30, 2017
BUY
$113.59 - $123.78 $2.45 Million - $2.67 Million
21,544
21,544 $2.6 Million

Others Institutions Holding TECH

# of Institutions
628
Shares Held
160M
Call Options Held
90K
Put Options Held
14.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $1.83B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email